Status:
COMPLETED
Comparison of Primary and Secondary Prevention of Postpartum Hemorrhage at the Community Level in Egypt
Lead Sponsor:
Gynuity Health Projects
Collaborating Sponsors:
Ministry of Health and Population, Egypt
University of Alexandria
Conditions:
Postpartum Hemorrhage
Eligibility:
FEMALE
Phase:
PHASE4
Brief Summary
The objective of this study is to compare two community-level strategies: either selective, early administration of 800 mcg sublingual misoprostol to women for secondary prevention of postpartum hemor...
Eligibility Criteria
Inclusion
- Willing and able to give informed consent
- Vaginal delivery
- Agrees to participate in follow-up interview
- Agrees to have pre- and post-hemoglobin taken
- Delivery at woman's home or at the primary health unit (PHU)
Exclusion
- Too advanced into active labor to provide consent
- Known allergy to misoprostol and/or other prostaglandin
- Pregnancy complications, such as hypertension, suspected multiple pregnancy, previous caesarean section, suspected still birth, ante-partum hemorrhage, and previous complication in the third trimester
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2016
Estimated Enrollment :
2827 Patients enrolled
Trial Details
Trial ID
NCT02226588
Start Date
October 1 2014
End Date
January 1 2016
Last Update
February 15 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Primary Health Care Units
Damanhur, El Beheira, Egypt
2
Primary Health Care Units
Kafr El Dawar, El Beheira, Egypt